NERV Shares Outstanding History



Below is a table of the NERV shares outstanding history going back to 6/26/2014:

Date NERV Shares Outstanding
6/26/20142.11M
8/6/20142.30M
11/5/20142.30M
3/20/20153.09M
4/22/20153.09M
7/31/20153.09M
10/30/20153.09M
3/9/20163.47M
4/28/20163.49M
7/29/20164.35M
10/28/20164.35M
3/10/20174.41M
5/1/20174.59M
7/31/20175.31M
10/31/20174.84M
3/9/20184.84M
5/1/20184.84M
7/31/20184.85M
10/31/20184.86M
3/7/20194.88M
5/1/20194.88M
7/31/20194.88M
10/30/20194.88M
3/5/20204.90M
4/29/20204.90M
7/29/20205.15M
10/28/20205.33M
3/4/20215.34M
5/7/20215.34M
7/28/20215.34M
11/3/20215.34M
2/24/20225.34M
4/29/20225.34M
8/4/20225.34M
11/4/20225.34M
3/3/20235.34M
4/17/20235.34M
5/10/20235.57M
7/27/20236.99M
11/2/20236.99M
2/19/20246.99M

Also see: NERV Market Cap History
NERV YTD Return
NERV Historical Shares Outstanding:
+13.20% CAGR
NERV Historical Shares Outstanding: +13.20% CAGR

Mouse over chart for data details
6/26/2014 ...2/19/2024
Minerva Neurosciences is a clinical-stage biopharmaceutical company focused on the development and commercialization of product candidates to treat patients suffering from central nervous system diseases. Co.'s primary product candidate is roluperidone, a compound it is developing for the treatment of negative symptoms in patients with schizophrenia. Co. holds the license to roluperidone from Mitsubishi Tanabe Pharma Corporation with the rights to develop, sell and import roluperidone globally, excluding most of Asia. Co. also has exclusive rights to develop and commercialize MIN-301, a compound for the treatment of Parkinson's disease. We show 41 historical shares outstanding datapoints in our coverage of NERV's shares outstanding history.

Understanding the changing numbers of NERV shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NERV versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NERV by allowing them to research NERV shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree NERV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Minerva Neurosciences (NERV) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

NEUE Shares Outstanding History
NEXI Shares Outstanding History
NGM Shares Outstanding History
NK Shares Outstanding History
NKGN Shares Outstanding History
NKTR Shares Outstanding History
NKTX Shares Outstanding History
NLNK Shares Outstanding History
NLTX Shares Outstanding History
NMRA Shares Outstanding History
More Healthcare companies »

 

NERV Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.